Impact of nitric oxide deficiency on blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat  by Deng, Aihua et al.
Kidney International, Vol. 50 (1996), pp. 1132—1138
Impact of nitric oxide deficiency on blood pressure and
glomerular hemodynamic adaptations to pregnancy in the rat
AIHUA DENG, KEVIN ENGELS, and CHRIS BAYLIS
Department of Physiology, West Virginia University, Morgantown, West Virginia, USA
Impact of nitric oxide deficiency on blood pressure and glomerular
hemodynamic adaptations to pregnancy in the rat. Studies were con-
ducted to investigate the impact of nitric oxide synthesis inhibition on
blood pressure and glomerular hemodynamic adaptations to pregnancy in
the rat. In normal pregnancy, urinary excretion of NO2 + NO3 (NO),
reflecting increased nitric oxide (NO) production, progressively increased.
Blockade of NO production in virgin and late pregnant Sprague-Dawley
rats caused systemic hypertension, increased renal vascular resistance
(RVR), reductions in RPF but GFR remained unchanged. In cortical
nephrons, preglomerular and efferent arteriolar resistance (RA and RE)
were elevated and glomerular capillary blood pressure (PGC) increased
markedly. Glomerular plasma flow (QA) and the glomerular capillary
ultrafiltration coefficient, Kf, were reduced without change in single
nephron glomerular filtration rate (SNGFR) because of the large eleva-
tion in P0.. The pressor and glomerular hemodynamic responses to NO
blockade were similar in virgins and pregnancy. Urinary NO excretion
was markedly reduced in all groups with chronic NO blockade. Inhibition
was incomplete in pregnancy, however, and a level of NO production that
was adequate for normal BP and renal function in virgins, led to severe
vasoconstriction in pregnancy. The present studies suggest that chronic
NO deficiency leads to derangement of the hemodynamic adaptations of
pregnancy.
Normal pregnancy is characterized by plasma volume expan-
sion, vasodilation, falls in blood pressure (BP) and decreased
sensitivity to vasopressor agents [1-41. Renal vasodilation also
occurs during midterm normal pregnancy, leading to increases in
renal plasma flow (RPF) and glomerular filtration rate (GFR),
which have returned to nonpregnant levels close to term [1, 2, 5].
The mechanism(s) of these physiologic adaptations are currently
unknown although there is now evidence that the nitric oxide
system is importantly involved. It is particularly critical to under-
stand the mechanism(s) responsible for these adaptive changes in
normal pregnancy, since in preeclampsia, a common pregnancy-
induced disease in which hypertension develops, all these gesta-
tional adaptive responses are impaired [1, 61.
In recent years an endothelial control system has been discov-
ered which plays a profound role in physiologic regulation of BP
and renal function. In the nonpregnant rat, endogenously pro-
duced nitric oxide (NO) in vascular endothelial cells tonically
contributes to control of BP and renal function (7, 8]. In the
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pregnant rodent the plasma level and urinary excretion of cGMP
(the second messenger of NO), and NO2 + NO3 (N Ox; the stable
oxidation products of NO) are increased [9], there is increased
activity and expression of the endothelial NO synthase [10, 111,
and recent evidence suggests that NO mediates the midterm
gestational renal vasodilation [12]. Urinary cGMP excretion is
increased in normal pregnant women although the impact of
pregnancy on NO excretion is currently controversial [13, 14].
Thus, NO may mediate the physiologic systemic and renal hemo-
dynamic adaptations of pregnancy.
Preeclampsia is clinically silent during the first half of preg-
nancy, and the symptoms of varying severity are manifest towards
term [6]. There is evidence of general vascular endothelial dam-
age in preeclampsia [151 and it is possible that a relative NO
deficiency in pregnancy may result in the systemic manifestations
of the disease. To investigate the consequences of NO deficiency
in pregnancy, we determined the blood pressure and glomerular
hemodynamic responses to chronic NO blockade in late preg-
nancy in the rat. We also measured 24-hour NO excretion as an
index of overall NO production.
Methods
Studies were conducted on five groups of female Sprague-
Dawley rats: normal virgins (NORV, N = 5), normal pregnants(NORP, N = 6), L-NAME-treated virgins, group 1 (NAMVI,
N = 5), L-NAME-treated virgins, group 2 (NAMV2, N = 5), and
L-NAME-treated pregnants (NAMP, N = 6). All rats were
allowed free access to a standard rat pellet diet and tap water.
Rats in the L-NAME-treated groups were placed on oral L-
NAME in the drinking water for fourteen consecutive days
immediately after receiving an i.v. holus of L-NAME (10 mg/kg; a
dose that produces the maximum, acute rise in BP [16]). The
NAMP rats started L-NAME treatment on gestational day 4, and
both NAMP and NAMVI rats received L-NAME at a concentra-
tion of 100 mg L-NAME/liter drinking water, which was changed
every other day. The amount of water intake was monitored, from
which the daily L-NAME intake was calculated (Fig. 1). The
L-NAME intake remained approximately constant in NAMVI
throughout the 14 day period (9.8 0.2 mg/kg/24 hr) but
increased progressively in NAMP (16.5 0.5 mg/kg/24 hr) due to
the increased water intake. In NAMV2 rats, each virgin female
was paired to a NAMP rat and the concentration of L-NAME in
the drinking water was progressively increased so that the 24-hour
L-NAME intake was equal to that in the paired NAMP through-
out the 14 day period and averaged 16.5 0.5 mg/kg/mm.
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Fig. 1. The daily oral intake of the NO synthesis inhibitor, nitro-L-arginine
methylester (L-NAME) in a group of pregnant rats (NAMP; •), given
L-NAME in the drinking water from day 4 to day 18 of pregnancy. A group
of age-matched virgin rats (NAMV1; 0) also received L-NAME in the
same concentration (100 mg/liter) over a 14 day period. *Denotes a
difference in L-NAME intake between pregnant and virgin rats, due to the
increased water intake in pregnancy.
Twenty-four hour urine collections were made before L-NAME,
immediately after the i.v. bolus of L-NAME, day 6 after L-NAME
treatment (midterm pregnancy, days 10 to 11), and day 13 of
L-NAME treatment (late pregnancy, days 17 to 18), respectively,
for measurement of urinaiy excretion of NO In an additional
group of four normal rats, 24 hour urines were collected in the
virgin state, and at days 4 to 5, 10 to 11 and 17 to 18 of pregnancy;
24-hour food intake was also measured and the food analyzed for
NO content. All 24-hour urine collections were frozen and later
analyzed for NO content. On day 14 of L-NAME or drinking
water, NORV, NORP, NAMV1 and NAMP rats were anesthe-
tized and studied by glomerular micropuncture. NAMV2 rats
were anesthetized and surgically prepared similarly to the other
four groups and the arterial blood pressure (BP) was measured;
however, these animals were too fragile to permit the lengthy,
complete glomerular hemodynamic measurements.
Rats were anesthetized with mactin (100 to 120 mg/kg, i.p.;
Research Biochemicals Inc., Natick, MA, USA), placed on a
temperature-regulated micropuncture table and rectal tempera-
ture maintained at 36° to 38°C. A tracheotomy was performed and
polyethylene catheters (PESO) were inserted into the right femo-
ral artery for blood sampling and measurement of arterial blood
pressure (BP), into the right femoral vein for infusion of artificial
plasma (2.5 g% bovine serum albumin, 2.5 g% bovine globulins in
lactated Ringer solution) and into a jugular vein for infusion of
tritiated inulin. BP was monitored by a Gould-Statham transducer
connected to a direct-writing recorder (Gilson, Middleton, WI,
USA). An i.v. infusion of artificial plasma was given at the rate of
1% body wt/hr for the first 45 minutes of surgery, thereafter, at
0.15% body wt/hr for the remainder of the experiment to maintain
constant plasma volume. Isotonic NaCI solution containing —100
iCi/ml tritiated-inulin was infused i.v. at a rate of 1 to 1.5 mI/hr
during equilibration and throughout the experiment.
The left kidney was exposed through a midline and left subeos-
tal incision, gently separated from the surrounding perirenal fat,
supported on a flat Lucite plate and the kidney surface was
illuminated with a fibre optic light source attached to a quartz
glass light rod and slowly superfused with warm, 0.9% NaCI
solution (34 to 36°C). The left ureter was catheterized with PE1O
for collection of urine and a catheter (PE5O) attached to a bent,
cut 26G needle was inserted, retrograde, into the left renal vein
for periodic sampling of renal venous blood. A 60-minute equil-
ibration period was allowed after completion of surgery before
any measurements were made.
Two exactly timed urine collections (25 to 30 mm) were made
directly into graduated glass tubes for determination of urine flow
(V) and urinary inulin concentration. Blood samples (200 trl)
were taken at the midpoint of urine collection periods from the
femoral artery and renal vein for measurements of hematoerit
(het), plasma protein concentration (CA) and plasma inulin
concentration. Coincident with the urine collections, the following
micropuneture measurements were made. Exactly timed (2 to 3
mm) samples of tubule fluid were collected at random sites on the
perfused kidney surface by puncture of six to eight surface
proximal convoluted tubules, for determination of inulin content.
Efferent arteriolar (post-glomerular) blood was collected by punc-
ture of three to five superficial star vessels for determination of
efferent arteriolar plasma protein concentration (CE). Hydrostatic
pressures were measured in surface efferent arterioles and prox-
imal tubules using the servo-null micropressure measuring system
(Model 4A; 1PM, San Diego, CA, USA). GC was measured
indirectly: wax blocks were inserted into five to seven mid-
proximal surface segments to completely obstruct fluid flow. The
hydrostatic pressure in the tubule proximal to the block rises until
it reaches the "stop-flow" pressure (PSF), when filtration stopped.
SF was measured at the earliest proximal segment.
The activities of tritiated inulin were measured in aliquots of
arterial and renal venous plasma (5 s.d), urine (1 in) and the entire
tubular fluid sample, which allowed calculations of SNGFR, GFR,
RVR and RPF. Protein concentrations (C) in femoral (CA) and
efferent arteriolar (CE) plasma were measured using a microad-
aptation of the Lowry method [17] and the colloid osmotic
pressures were calculated [18]. Together, these measurements
allow calculation of SNGFR, single nephron filtration fraction
(SNFF), QA, RA, RE and Kf [18]. Since the values of SNGFR
were obtained from proximal collections, these may slightly
overestimate the true SNGFR, because of the interuption of flow
to the macula densa. Urinary NO concentration was measured
by a reduction of urinary NO3 to NO2 with the nitrate reductase
enzyme and the NO2 generated from NO3 by the nitrate reduetase
enzyme, and any NO2 in the urine was detected and quantitated
by the Gricss reaction [191. Briefly, 125 1.d urine samples (diluted
3 to 4X) were incubated with 100 .nlbuffer (1.0 M HEPES, 2.4 mvi
ammonium formate, pH 7.2) and 25 1.d nitrate reductase enzyme
(100 mg/mI), for one hour at 37°C in a shaking water bath. The
tubes were spun at 2000 g for 10 minutes and the 100 id of the
supernatant was mixed with 150 1.d Griess reagent in 96 well plates
and read at 543 nm in an ELISA plate reader. NO2 standards
were run in the range of 5 to 500 m as well as a 100 mt NO3
standard, to test for complete reduction by the enzyme. The NO
content of the rat food was measured in aliquots of solutions of
2 4 6 8 10 12 14
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food dissolved in distilled water (0.05 to 0.3 gJml) and was found
to average 263 nmol NO/g of food.
The statistical comparison of all renal functional data were
made by unpaired t-test comparing virgin and late pregnancy
within either control or L-NAME-treated groups and by ANOVA
for certain preplanned comparisons between groups. Statistics on
NAME intake and 24-hour urinary excretion of NO within
groups were done by repeated measures ANOVA with univariate
tests of hypotheses for within subjects effects. Comparisons on
these variables between groups were by repeated measures
ANOVA with analysis of variance of contrast variables. Statistical
significance is assumed where P < 0.05.
Results
As shown in Figure 2, 24-hour urinary NO excretion increased
progressively during pregnancy so that by close to term, UNOXV
had increased three to four times above the virgin value. As also
shown, dietary NO intake also increased because of increased
food consumption, but the increased intake could only account for
a small fraction of the increased urinary output, suggesting that
increased NO production in pregnancy must account for the
balance. Figure 3 gives the 24-hour UNOXV values for NAMP,
NAMV1 and NAMV2 rats before and during pregnancy. The
mean BP for each group, obtained in the terminal study, is given
on the far right. In NAMP, NAME lowered Ur.)XV to below the
nonpregnant baseline value both in early and mid-pregnancy;
however, by late pregnancy, UNQXV rose back to the baseline
(virgin) unblocked value despite a continued high (increasing)
NAME intake (Fig. 1), which was on average 16.5 0.5 mg/kg/24
hr. Nevertheless, the BP in these late pregnant rats was high
(155 4 mm Hg). In virgins on a matched NAME intake
(NAMV2), a maintained and greater suppression of NO produc-
tion (vs. NAMP) was seen and BP was higher (186 6 mm Hg)
versus pregnant rats (Fig. 3). In NAMVI rats, which received the
lower dose of L-NAME (an average of 9.8 0.2 mg/kg/24 hr), NO
blockade (as assessed by reduced 24 hr UNOXV) was also main-
tained for the 14 day period of L-NAME administration and was
'4,
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Fig. 3. The 24-hour urinaty nitrate + nitrite excretion (UNOXV) in the
control, baseline state and in a group of pregnant rats (NAMP, • BP =
154 5) receiving L-NAME from day 4 to day 18 of pregnancy in an average
dose of 16.5 0.5 mg/kg/24 hr. Data are also shown for 2 groups of virgin
rats given L-NAME over a 14 day time course, NAMV1 (0; BP = 145
7) received an average dose of 9.8 0.2 mg/kg/24 hr and NAMV2 (;
BP = 186 6) received an average dose of 16.5 0.5 mg!kg/24 hr.
*Denotes a difference (P < 0.01) in UNOXV at week 3 between pregnant
rats and both groups of virgins.
similar to the NAMV2 group. Of note, UNOXV was lower in
NAMV1 rats than in NAMP, despite the fact that NAMV1 rats
had received a lower dose of L-NAME. BP was elevated in both
groups of virgins but by less in NAMV1 versus NAMV2 rats (P <
0.01), despite a similarity of 24-hour UNOXV profiles (Fig. 3).
Data are summarized for whole kidney and single nephron
function in NORV, NORP, NAMVI and NAMP groups in Table
1.
Normal pregnant versus normal virgins
Normal late pregnant rats (NORP) exhibited significant de-
creases in hct compared to normal virgins (NORV), suggesting
plasma volume expansion, and a late gestational reduction in BP,
suggesting a decline in total peripheral vascular resistance (TPR).
There was no difference in renal or glomerular hemodynamics
between late pregnant rats and normal virgins. This is consistent
with previous findings by us and others that the increased
glomerular filtration rate (GFR), renal plasma flow (RPF), single
nephron glomerular filtration rate (SNGFR) and glomerular
plasma flow (QA) and decreased total renal vascular resistance
(RVR) seen at midterm pregnancy, return towards nonpregnant
values close to term [5].
NAME treated versus nortnal virgins
In virgin rats, chronic systemic NO blockade caused increased
bet (presumably secondary to volume contraction), systemic hy-
pertension and increased RVR that lcd to pronounced reductions
in RPF. GFR was unchanged and thus filtration fraction (FF)
increased (Table 1). In the cortical nephron population, both RA
and RE were elevated with chronic NO blockade. Because of the
increase in RE and BP and despite the rise in RA, Gc rose
markedly. QA was significantly reduced due to the increases in
segmental arteriolar resistances and there was no change in
SNGFR because of the large elevation in hydrostatic pressure
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Fig. 2. The 24-hour urinary excretion of nitrate + nitrate (l]NOXV, •) the
stable oxidation products of nitric oxide (NO), in a group of normal rats,
before and early (week 1), mid (week 2) and late (week 3) in pregnancy. The
N0 intake in the food (X) is also shown. *Denotes a difference versus the
control, pre-pregnancy value.
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Table 1. Summary of whole kidney and single ncphron hemodynamic changes in normal control (NOR) and L-NAME (NAM) treated late
pregnant (P) and virgin (V) rats
Kf
RVR RA RE ni/si
Hct BP GFR RPF mm Hg/ SNGFR °A ha r'r OC dyn s •cn1)< (mm% mm Hg mi/mm FF (mi/mm) ni/mm mm Hg 100 Hg)
NORP 36 88 0.79 2.72 0.30 20 35 127 17 28 47 1.8 1.6 0.0441 --0.06 ±1)17 ±0.0! ±1 ±2 ±11 ±0.5 ±1 --1 ±0.3 0.3 ±0.004
NORV 41 101 0.77 2.67 0.31 24 33 125 17 28 49 2.0 1.6 0.040
±1 ±3 ±1)07 ±0.24 ±0.03 ±4 ±3 ±11 ±0.3 ±1 ±1 ±0.2 ±0.2 0.003
NAMV 44 145 0.72 1.61 0.46 58 40 91 19 47 75 3.5 4.1 0.021
±1 ±7 ÷0.10 ±0.24 ±0.01 ±14 ±2 --12 ±0.9 ±2 --2 ±0.2 0.3 ±0.002
NAMP 38 154 0.73 1.71 0.42 58 38 95 19 44 77 4.4 5.3 0.018
±2 ±5 --0.07 ±0.17 ±0.02 ±7 ±4 ±12 ±0.6 ±2 ±2 ±0.8 ±0.9 ±0.002
Pr NORP vs. NORV
<0.01 <0.05 NS NS NS NS NS NS NS NS NS NS NS NS
P: NORV vs. NAMV
<0.01 <0.01 NS <0.02 <0.01 <0.01 MS <0.05 NS <0.01 <0.01 <0.05 <0.01 <0.01
P: NAMV vs. NAMP
<0.01 NS NS NS NS NS NS NS NS NS MS NS NS NS
Pr NORP vs. NAMP
<0.01 <0.01 NS <0.02 <0.01 <0.01 NS <0.05 <0.05 <0.0! <t).01 <0.01 <0.01 <0.01
All data are mean ± SE. Statistics are done by ANOVA. Groups are: NAMV1, NAME-treated virgin (9.8 ± 0.2 mg/kg/24 hr); NAMP, NAME-treated
late pregnant (16.5 ± 0.5 mg/kg124 hr); NORV, normal virgin; NORP, normal late pregnancy.
gradient (P — r), and thus, single nephron filtration fraction,
SNFF increased (not shown). irA did not change and n increased
significantly. The glomerular capillary ultrafiltration coefficient,
K0 was reduced by —50%.
NAME treated pregnant versus NAME treated virgins
NO blockade prevented the normal gestational late fall in BP,
and in fact produced systemic hypertension in late pregnant
(NAMP) rats. Both BP and P0. were similarly and markedly
elevated in NAMP and NAMVI rats, despite the fact that NO
production is higher in NAMP. At the whole kidney and single
nephron level a similar pattern of vasoconstriction, reduced
plasma flow and K1 and unchanged filtration rate was seen in both
groups of L-NAME treated rats. The only hemodynamic differ-
ence between NAMP and NAMV was a significant decrease in hct
in NAMP, reflecting persistent plasma volume expansion Table
1).
NAME treated versus normal pregnant rats
Compared with normal pregnancy (NORP), chronic L-NAME
treated pregnant (NAMP) rats developed severe systemic hyper-
tension. At the whole kidney level an increase in FF was the result
of a reduction in RPF due to profound increases in RVR with
unchanged GFR. At the single nephron level, TA did not change
and ITF increased. There were large rises in segmental arteriolar
resistances, RA and RE. As with NAMV, the rise in RE, together
with increased BP resulted in glomerular capillary hypertension,
despite the increase in RA. QA was reduced with unchanged
SNGFR leading to a rise in SNFF. With chronic NO blockade in
pregnant rats K1 was reduced by approximately 50% compared
with normal pregnant rats. Overall, both virgin and late pregnant
rats responded similarly to chronic systemic NO blockade.
Discussion
The present studies confirm earlier work by Conrad and
colleagues [9], that during normal pregnancy in rats, the 24-hour
urinary excretion of NO increases progressively and reaches a
maximum by late pregnancy. The amount of 24 hour UNOXV is
influenced by NO intake (in the diet), absorption from the GI
tract, renal handling of NOR, as well as de novo NO synthesis [201.
Based on metabolic studies, it seems that balance is rapidly
restored (within 24 to 48 hr) when NO intake is varied and the
majority of NO excretion is via the kidney [20]. Therefore, when
corrected for NO intake, 24-hour UNOXV reflects total (periph-
eral and renal) NO production and as shown by us, the gestational
rise in UN0XV greatly exceeds the dietary NO intake, demon-
strating a net increase in NO production. In pregnancy the
maximum rise in UNOxV excretion occurs late in pregnancy and
is correlated with the fall in BP due to the reduction in peripheral
vascular resistance. At this time the RVR is not different from the
nonpregnant value, and thus we anticipate that renal NO produc-
tion is unlikely to be high. Therefore we interpret the increased
urinary NO excretion of late pregnancy to reflect increased NO
production in other vascular beds that causes the late gestational
decline in peripheral vascular resistance. It is likely that the
increase in urinary NO reflects NO generated from vascular
endothelium, peripheral and central neuronal sites as well as
elsewhere in the body, and may thus be reflecting nonvasodilatory
as well as vasodilatory NO. In the studies by Conrad et al, in
addition to 24 hour UNOXV, increases in plasma NO concentra-
tion were also observed during gestation that were closely corre-
lated with increases in cGMP, the second messenger of NO [9].
Increased cGMP has also been reported in earlier studies in both
normal human and rat pregnancies [13, 211, and in the rat the
metabolic clearance rate of cGMP was not altered. Therefore, the
increase in urinary and plasma cGMP reflected increased tissue
cGMP production [21].
In vivo studies suggest that NO is responsible for the pregnancy
associated refractoriness to the pressor action of administered
vasoconstrictors [4j, although in vitro studies have been more
variable and show substantial differences in the role of NO in
various regional vascular beds [22-25]. Increased eNOS has
recently been reported in the aorta of the pregnant rat [11], and
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in guinea pigs the activity of calcium-dependent (constitutive) NO
synthase (NOS) is increased in uterine artery, kidney, heart as well
as other tissues in both early and late pregnancies [10, 261.
Increased expression of mRNA levels for both constitutive NOS
isoforms (endothelial and neuronal) have been observed in a
variety of locations in late pregnant guinea pig, and estrogen may
provide the primary stimulus [101; however, since estrogen levels
are low in rats until late in pregnancy [271 the precise role of
estrogens remains to be determined.
In addition to a general increase in vascular NO production,
which contributes to the gestational vascular refractoriness and
fall in BP, increased NO production apparently plays a role in the
renal vasodilation of pregnancy. It is clear that NO is an impor-
tant, physiologic renal vasodilator [8]. Recent work in the con-
scious pregnant rat suggests that the midterm renal vasodilation is
due to increased NO production [12]. Finally, chronic NO block-
ade during pregnancy leads to suppression of the normal periph-
eral and renal vasodilation [28] and produces a pattern that
resembles the symptoms of preeclampsia. Therefore, increased
NO production may be responsible for the peripheral and renal
vasodilation in the normal pregnant rat.
In the present study we have further investigated the effect of
chronic NO blockade in pregnancy in the rat. We examined the
effect of chronic L-NAME on 24-hour urinary NO excretion
throughout pregnancy, and on BP and glomerular hemodynamics
close to term. Since renal and hypertensive complications of
preeclampsia manifest late in human pregnancy, we chose to
make our functional observations in close to term rats. These
studies show that NO synthesis is more difficult to suppress in
pregnancy, which presumably reflects enhanced synthetic capac-
ity. Even with incomplete suppression of NO synthesis, prevention
of the normal large gestational rise in NO production results in
hypertensive pregnancy. In fact, a level of NO production that is
appropriate for control of vascular tone in normotensive (non-NO
blocked) virgins is inadequate in the L-NAME-treated pregnant
rat. Therefore, BP and RVR increase with the development of
glomerular capillary hypertension. These high values of P0, if
sustained, will lead to glomerular structural damage [5]. Of
particular note, NO production must be increased in late preg-
nancy in order to accomodate the altered hemodynamic status
and permit the late fall in BP. This increased NO production in
normal pregnancy presumably acts by maintaining a new balance
between vasodilator and vasoconstrictor influences, thus accom-
modating the expanded plasma volume.
It is likely that the systemic and renal hemodynamic responses
to chronic NO inhibition in nonpregnant states as well as in
pregnancy are the result of an imbalance between vasodilatory
and vasoconstrictor systems. In normal pregnancy the plasma
level of angiotension II (Ang II) is elevated and systemic vascular
response to administered Ang II is blunted [1, 3]. Studies in the
rat have suggested that pregnancy-induced refractoriness to Ang
II as well as other vasopressor agents, AVP and NE, is due to NO
since the refractoriness can be reversed by acute inhibition of NO
synthesis [4]. The relationship between NO and Ang II in control
of RVR depends on the level of endogenous intrarenal Ang II,
and when Ang II levels are elevated, renal hemodynamics are
largely mediated by the balance between NO and Ang II [8].
Therefore, chronic NO synthesis inhibition will amplify actions of
Ang II when the Ang II synthesis is increased, as occurs in
pregnancy. Other vasopressor systems may also be potentiated
during states of NO deficiency.
Chronic partial NO blockade in male rats causes hypertension,
renal vasoconstriction, glomerular hypertension, falls in K1. and
eventual glomerular injury after approximately two months [29].
In the present study, two weeks of NO blockade in virgin females
causes hypertension, marked renal vasoconstriction with increases
in both RA and RE, severe glomerular hypertension and falls in
K1., probably secondary to mesangial cell contraction [8]. A similar
pattern was seen in chronically NO blocked late pregnant rats. In
fact, the only significant hemodynamic difference between virgin
and pregnant chronically NO blocked animals was the lower hct in
NAMP that was indicative of some persistent plasma volume
expansion. Of importance, the normal late gestational fall in
systemic BP was suppressed such that BP was high in NAMP and
nonsignificantly greater than NAMV. It should be emphasized
that similar hypertensive and renal vasoconstrictor responses
occurred in pregnant and virgin rats, despite higher levels of
residual NO synthesis in pregnant rats. Presumably, if equivalent
levels of NO synthesis inhibition had been achieved in pregnant
and virgin rats given NAME, the pressor and renal vasoconstrictor
response in pregnancy would be exaggerated.
In this and in earlier studies we observed that in normal
pregnancy, the RVR is increasing back towards the nonpregnant
value, close to term. Thus, GFR, SNGFR, RPF, QA, RA, R and
P0 are similar in late pregnant and virgin rats, despite the large
volume expansion (reflected by low hct), peripheral vasodilation
and a fall in BP [5]. In comparing the NO blocked (NAMP) and
normal (NORP) pregnant rats it is evident that systemic BP,
RVR, RA, R0 and GC are much higher, while RPF, QA and Kf
are much lower in NO-blocked versus normal pregnant rats.
Despite the marked renal vasoconstriction and low I( of NO
deficiency, the glomerular hypertension is more than sufficient to
prevent declines in GFR or SNGFR.
In this study, we have shown that the normal vasodilatoiy effect
of pregnancy is lost due to NO blockade. This contrasts with other
hypertensive states where late pregnancy is uniformly antihyper-
tensive in the spontaneously hypertensive rat, DOCA/salt hyper-
tension, Goldblatt hypertension, severe renal ablation and adrenal
regeneration [30-32]. We have also found that in rats with 5/6
renal ablation, the kidney as well as the periphery vasodilates
close to term [321. Thus, chronic NO blockade-induced hyperten-
sion is unique in preventing the midterm renal and later periph-
eral vasodilation response to pregnancy, and suggests a causal role
for NO in mediating the gestational vasodilation. Recent prelim-
inary observations suggest that L-arginine supplementation re-
verses the hypertension, proteinuria and growth retardation seen
with chronic L-NAME administration to pregnant rats, further
reinforcing the notion that the adverse changes with L-NAME
result from NO synthesis inhibition [33].
At present, there is no consensus from clinical studies on the
impact of normal or preeclamptic pregnancy on NO production,
as measured by NO and certain prol)Iems with the clinical
assessment of NO activity, by NO determination, may be respon-
sible [14]. A relative arginine deficiency develops in normal
pregnant women, perhaps reflecting increased NO synthesis [34-
36]. The circulating endogenous NOS inhibitor asymmetric di-
methyl arginine (ADMA) falls in normal pregnancy and increases
in preeclampsia [37], providing one mechanism by which NO
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production would be reduced. The few studies on vascular reac-
tivity in maternal resistance vessels are conflicting. Although no
changes are seen in endothelium dependent relaxation of small
arteries from normal pregnant or preeclamptic women studied in
vitro [38, 39], an exaggerated vasoconstriction to NO synthesis
inhibition occurs in vivo in the hand circulation of normal
pregnant versus nonpregnant women, suggesting increased tonic
NO release [40]. Increased 24-hour urinary excretions of cGMP
seen in normal pregnancy are reduced in preeclampsia [13, 14,
41].
To summarize, the adverse interactions between pregnancy and
hypertension induced by NO blockade in rats in the present and
a previous study [28] include systemic hypertension sustained
throughout the pregnancy, prevention of the normal midterm
gestational renal vasodilation, high values of RVR and PGC at
term leading, not surprisingly, to proteirturia as well as poor fetal
and maternal outcomes. These are similar to the symptoms seen
in preeclamptic women. In late pregnancy this vasoconstricted
state with chronic NAME exists despite absolute levels of NO
production that are equivalent to normal (unblocked) NO levels
seen in the virgin. Therefore, pregnancy requires large increases
in NO production to accomodate the increased level of vasocon-
strictor influences and expanded plasma volume.
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